O23 Stock Overview
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ZimVie Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$14.60 |
| 52 Week High | US$19.10 |
| 52 Week Low | US$6.25 |
| Beta | 2.01 |
| 1 Month Change | -1.35% |
| 3 Month Change | -3.31% |
| 1 Year Change | 100.00% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -33.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| O23 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -4.6% | -5.4% | -2.5% |
| 1Y | 100.0% | -6.2% | -0.4% |
Return vs Industry: O23 exceeded the German Medical Equipment industry which returned -3.3% over the past year.
Return vs Market: O23 exceeded the German Market which returned 1% over the past year.
Price Volatility
| O23 volatility | |
|---|---|
| O23 Average Weekly Movement | 8.9% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: O23's share price has been volatile over the past 3 months.
Volatility Over Time: O23's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 2,600 | Vafa Jamali | www.zimvie.com |
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name.
ZimVie Inc. Fundamentals Summary
| O23 fundamental statistics | |
|---|---|
| Market cap | €400.27m |
| Earnings (TTM) | -€52.53m |
| Revenue (TTM) | €428.71m |
0.9x
P/S Ratio-7.4x
P/E RatioIs O23 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| O23 income statement (TTM) | |
|---|---|
| Revenue | US$457.43m |
| Cost of Revenue | US$167.05m |
| Gross Profit | US$290.38m |
| Other Expenses | US$346.43m |
| Earnings | -US$56.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.06 |
| Gross Margin | 63.48% |
| Net Profit Margin | -12.25% |
| Debt/Equity Ratio | 124.3% |
How did O23 perform over the long term?
See historical performance and comparison